Not enough data
Ryner Lai's articles primarily focus on scientific and healthcare topics, particularly medical research, clinical trials, disease treatment, drug therapies, and case reports. The coverage attributes indicate a heavy reliance on data citations.
Given the nature of Ryner's coverage, pitches should highlight access to unique or groundbreaking data relevant to medical research or clinical trials. Furthermore, experts who can provide insightful analysis based on concrete data are likely to resonate with Ryner's approach.
While there is no specific geographic focus mentioned for Ryner Lai’s coverage area in the provided information, it would be beneficial to offer insights that have global implications within the field of medical research and healthcare given the broad nature of their themes covered.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Ryner Lai
Anselamimab therapy is associated with improved all-cause mortality (ACM) and reduced cardiovascular hospitalizations (CVHs) in patients with kappa immunoglobulin light chain (AL) amyloidosis, according to a study published in the Journal of Clinical Oncology.
A 28-year-old male patient was diagnosed with severe hemophilia B (ie, factor IX levels under 1%) shortly after birth. His family history included a maternal uncle who had the disease.
By: Ryner Lai
Oral sonrotoclax was associated with rapid and durable responses among patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) who were heavily pretreated, according to a study published in Hematologic Malignancy.
Yemen now ranks third highest in the world for measles cases, a sign of its collapsing healthcare system.
Two of three approved gene therapies for hemophilia have left the market and a fourth candidate went to a bankruptcy auction recently and found no buyer. The science worked but the business did not. What went wrong? And what does it mean for every gene therapy program that follows?
By: Ryner Lai
A diagnosis of HHT was associated with iron deficiency anemia, mucosal and gastrointestinal bleeding, and solid-organ arteriovenous malformations (AVMs), highlighting the need for early diagnosis, preventative care, and the continued development of effective disease-modifying therapies, according to a study published in Blood.
By: Ryner Lai
A study supports the therapeutic efficacy of voxelotor in adult patients with sickle cell disease (SCD), but concerns regarding its safety remain, according to an article published in Blood Red Cells & Iron.
A 36-year-old man is diagnosed with acute myeloid leukemia (AML) with adverse-risk cytogenetic and molecular features. He achieves a complete remission (CR1) after intensive induction therapy. Given his adverse-risk disease, his physicians assess him for allogeneic hematopoietic cell transplantation (allo-HCT) as post-remission therapy.
By: Ryner Lai
A study published in the European Journal of Haematology highlights the prognostic value of the SKY92 gene-expression signature in high-risk multiple myeloma (HR-MM) and demonstrates the feasibility of integrating genomic profiling with next-generation sequencing (NGS)-based minimal residual disease (MRD) assessment into routine clinical practice across Ireland.
By: Ryner Lai
The addition of acalabrutinib to front-line bendamustine-rituximab therapy significantly prolongs PFS and delays the need for subsequent treatments in older patients with previously untreated MCL.
